Disc up another 5.4% last night on impressive volume to a market cap of $2.5 Billion AUD. That is more than three times the valuation of CUV. CUV has the FDA, EMA drug and the absolute monopoly on EPP and great cash and profits with a Phase 3 into blockbuster Vitiligo. Loss making Disc just hoping to one day in many years to achieve approval in EPP and enter that market. I think it's fair to say shorters have had a big impact here at CUV as ASIC daily data shows and some effort needs to be made to protect shareholder interests right now via a share buyback. Disc is also so much better at attracting investor interest than at CUV and they need to lift their game a lot in that area - after all the newsletter stated it only took one institution buying a lot of shares in one month to take the CUV price over $40.
All IMO DYOR
- Forums
- ASX - By Stock
- CUV
- Disc Medicine - Best comparison stock to Clinuvel
Disc Medicine - Best comparison stock to Clinuvel, page-16
-
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$17.38 |
Change
2.210(14.6%) |
Mkt cap ! $870.8M |
Open | High | Low | Value | Volume |
$15.20 | $17.71 | $15.16 | $5.878M | 346.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $17.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.39 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 142 | 17.300 |
1 | 116 | 17.220 |
1 | 160 | 17.180 |
1 | 700 | 17.100 |
1 | 32 | 17.050 |
Price($) | Vol. | No. |
---|---|---|
17.390 | 100 | 1 |
17.490 | 715 | 2 |
17.500 | 1138 | 2 |
17.550 | 26 | 1 |
17.580 | 100 | 1 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |